When this marker is used along with other laboratory parameters such as (CRP) and (WBC) patient outcome can be predicted more precisely (17).Procalcitonin levels is now considered as a marker for determining pneumonia severity as well as the antibiotic choice and hospitalization decisions in patients with (CAP) (13, 15, 18). This evidence concerns the gene CRP and susceptibility to pneumonia measurement.